Skip to main content
Mojun Zhu, MD, Oncology, Rochester, MN

Mojun Zhu MD

Gastrointestinal Cancer


GI Oncologist

Join to View Full Profile
  • 200 1st St SWRochester, MN 55905

  • Phone+1 507-284-2511

Dr. Zhu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2018 - 2021
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 2015 - 2018
  • Yale School of Medicine
    Yale School of MedicineClass of 2015

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2018 - 2026
  • CT State Medical License
    CT State Medical License 2017 - 2018
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Young Investigator Award American Society of Clinical Oncology (ASCO), 2020
  • Outstanding Hematology/Oncology Fellow Award Minnesota Society of Clinical Oncology (MSCO), 2020

Publications & Presentations

PubMed

Lectures

  • Meta-analysis of prognostic biomarkers for pancreatic neuroendocrine tumors (PNETs). 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • As Stomach Cancer Rates Rise in Younger People, Knowing Symptoms and Family History Is Key
    As Stomach Cancer Rates Rise in Younger People, Knowing Symptoms and Family History Is KeyFebruary 11th, 2025
  • Chemoimmunotherapy Improves Pathologic Outcomes in Gastroesophageal Carcinoma
    Chemoimmunotherapy Improves Pathologic Outcomes in Gastroesophageal CarcinomaNovember 25th, 2023

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: